Nearly half a million people with diabetes end up in emergency rooms around the US every year due to the seizures and other consequences of dropping or spiking blood-sugar levels associated with the disease, researchers said.
To help prevent serious complications, scientists have developed the new glucose-sensing protein that could one day be part of an implantable monitoring device.
Most patients with diabetes track glucose levels by using a glucose metre. They prick a finger with a tiny needle to draw blood, which they apply to a test strip inserted into the metre.
As a result, many patients don't test their blood as often as they should, risking complications such as seizures.
For more continuous monitoring, some patients use implantable devices that measure blood-sugar as often as once a minute, but they have drawbacks.
They are expensive, can only be used for up to a week and are not as reliable as conventional metres.
The new study focused on a protein that has already been explored as a good candidate for use in a continuous glucose monitoring system. It's a glucose/galactose binding protein (GBP) that changes shape when it attaches to glucose.
The study was published in the journal ACS Chemical Biology.
